SmallCaps Daily Dives Deep with CEO Kraig Higginson to Discuss Aspire’s Mission to Enhance Efficacy and Reduce Side Effects New York, New York–(Newsfile Corp. – March 11, 2025) – Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP) (“Aspire” or the “Company”) is revolutionizing drug delivery through its proprietary sublingual technology, designed to …
Read More »